<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl2">
 <label>Table II</label>
 <caption>
  <p>Summary of large case series and registry data of autoimmune disease patients infected or exposed to SARS-CoV-2</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Characteristics
     <xref rid="tbl2fnlowast" ref-type="table-fn">∗</xref>
    </th>
    <th colspan="3">Studies
     <hr/>
    </th>
   </tr>
   <tr>
    <th>Haberman et al
     <xref rid="bib71" ref-type="bibr">
      <sup>71</sup>
     </xref>
    </th>
    <th>Gianfrancesco et al
     <xref rid="bib72" ref-type="bibr">
      <sup>72</sup>
     </xref>
    </th>
    <th>Brenner et al
     <xref rid="bib73" ref-type="bibr">
      <sup>73</sup>
     </xref>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Total number of patients
     <xref rid="tbl2fndagger" ref-type="table-fn">†</xref>
    </td>
    <td align="center">86</td>
    <td align="center">110</td>
    <td align="center">525</td>
   </tr>
   <tr>
    <td>Confirmed cases of COVID-19</td>
    <td align="center">59 (69)</td>
    <td align="center">110 (100)</td>
    <td align="center">525 (100)</td>
   </tr>
   <tr>
    <td>Age, mean y</td>
    <td align="center">46</td>
    <td align="center">N/A
     <xref rid="tbl2fnddagger" ref-type="table-fn">‡</xref>
    </td>
    <td align="center">43</td>
   </tr>
   <tr>
    <td>Female sex</td>
    <td align="center">49 (57)</td>
    <td align="center">79 (72)</td>
    <td align="center">243 (46.3)</td>
   </tr>
   <tr>
    <td>Most common diagnosis</td>
    <td align="center">PsA: 21 (24)</td>
    <td align="center">RA: 40 (36)</td>
    <td align="center">CD: 312 (59.4)</td>
   </tr>
   <tr>
    <td>Other diagnoses</td>
    <td align="center">RA: 20 (23)</td>
    <td align="center">PsA: 19 (17)</td>
    <td align="center">UC: 203 (38.7)</td>
   </tr>
   <tr>
    <td/>
    <td align="center">CD: 20 (23)</td>
    <td align="center">SLE: 19 (17)</td>
    <td align="center">IBD unspecified: 7 (1.3)</td>
   </tr>
   <tr>
    <td/>
    <td align="center">UC: 17 (20)</td>
    <td align="center">Other: 17 (15)
     <xref rid="tbl2fnsection" ref-type="table-fn">§</xref>
    </td>
    <td/>
   </tr>
   <tr>
    <td/>
    <td align="center">Psoriasis: 14 (16)</td>
    <td align="center">AS: 7 (6)</td>
    <td/>
   </tr>
   <tr>
    <td/>
    <td align="center">AS: 9 (10)</td>
    <td align="center">Vasculitis: 7 (6)</td>
    <td/>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="center">SjS: 5 (5)</td>
    <td/>
   </tr>
   <tr>
    <td>Medications</td>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Biologic drugs</td>
    <td align="center">TNFi: 38 (44)</td>
    <td align="center">Unspecified: 49 (45)</td>
    <td align="center">TNFi alone: 176 (33.5)</td>
   </tr>
   <tr>
    <td/>
    <td align="center">IL-17i: 6 (7)</td>
    <td/>
    <td align="center">IL-12/23i: 55 (10.5)</td>
   </tr>
   <tr>
    <td/>
    <td align="center">IL-12/23i: 6 (7)</td>
    <td/>
    <td align="center">TNFi + DMARD: 52 (9.9)</td>
   </tr>
   <tr>
    <td/>
    <td align="center">IL-23i: 3 (3)</td>
    <td/>
    <td align="center">α-Integrin: 50 (9.5)</td>
   </tr>
   <tr>
    <td>JAKi</td>
    <td align="center">6 (7)</td>
    <td align="center">5 (5)</td>
    <td align="center">8 (1.5)</td>
   </tr>
   <tr>
    <td>csDMARD</td>
    <td align="center">MTX: 17 (20)</td>
    <td align="center">69 (63)</td>
    <td align="center">110 (21)</td>
   </tr>
   <tr>
    <td>Hydroxychloroquine</td>
    <td align="center">8 (9)</td>
    <td align="center">N/A</td>
    <td align="center">0</td>
   </tr>
   <tr>
    <td>Hospitalization</td>
    <td align="center">14 (16)</td>
    <td align="center">39 (35)</td>
    <td align="center">161 (31)</td>
   </tr>
   <tr>
    <td>Deaths</td>
    <td align="center">1 (1)</td>
    <td align="center">6 (5)</td>
    <td align="center">16 (3)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <italic>AS</italic>, Ankylosing spondylitis; 
    <italic>CD</italic>, Crohn's disease; 
    <italic>COVID-19</italic>, coronavirus disease 2019; 
    <italic>csDMARD</italic>, conventional synthetic disease-modifying antirheumatic drug; 
    <italic>IBD</italic>, inflammatory bowel disease; 
    <italic>IL</italic>, interleukin; 
    <italic>JAK</italic>, Janus kinase inhibitor; 
    <italic>MTX</italic>, methotrexate; 
    <italic>N/A</italic>, not available; 
    <italic>PsA</italic>, psoriatic arthritis; 
    <italic>RA</italic>, rheumatoid arthritis; 
    <italic>SARS-Cov-2</italic>, severe acute respiratory syndrome coronavirus 2; 
    <italic>SjS</italic>, Sjögren syndrome; 
    <italic>SLE</italic>, systemic lupus erythematosus; 
    <italic>TNFi</italic>, tumor necrosis factor-α inhibitor; 
    <italic>UC</italic>, ulcerative colitis.
   </p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fnlowast">
   <label>∗</label>
   <p id="ntpara0030">Data are shown as number (%) or as indicated otherwise.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fndagger">
   <label>†</label>
   <p id="ntpara0035">Includes both confirmed and highly suspected cases of COVID-19.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fnddagger">
   <label>‡</label>
   <p id="ntpara0040">20% of patients were aged &gt;65 years.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fnsection">
   <label>§</label>
   <p id="ntpara0045">Other included (all with n &lt; 5): inflammatory myopathy, ocular inflammation, other inflammatory arthritis, polymyalgia rheumatica, sarcoidosis, systemic sclerosis, osteoporosis, psoriasis, isolated pulmonary capillaritis, gout, and autoinflammatory disease.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
